Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk
- 30 April 2009
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 203 (2), 346-352
- https://doi.org/10.1016/j.atherosclerosis.2008.07.042
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Genetic polymorphism in the pregnancy-associated plasma protein-A associated with acute myocardial infarctionCoronary Artery Disease, 2007
- Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophagesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Immunoassays Developed for Pregnancy-Associated Plasma Protein-A (PAPP-A) in Pregnancy May Not Recognize PAPP-A in Acute Coronary SyndromesClinical Chemistry, 2006
- Pregnancy‐associated plasma protein A: A biomarker in acute ST‐elevation myocardial infarction (STEMI)Annals of Medicine, 2006
- Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarctionThrombosis and Haemostasis, 2006
- Insulin-Like Growth Factor-1 as a Vascular Protective FactorCirculation, 2004
- Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatmentAmerican Heart Journal, 2003
- Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha productionEndocrinology, 1996